Literature DB >> 23931849

Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Masanori Kawakami1, Rie Ishikawa, Yosuke Amano, Mitsuhiro Sunohara, Kousuke Watanabe, Nobuya Ohishi, Yutaka Yatomi, Jun Nakajima, Masashi Fukayama, Takahide Nagase, Daiya Takai.   

Abstract

Previously, we reported that the overexpression of fer tyrosine kinase (FER), a non-receptor tyrosine kinase, is correlated with poor postoperative prognosis and cancer-cell survival in non-small cell lung cancer (NSCLC). In the present study, we further analyzed FER-overexpressed NSCLC cases and identified various patterns of chimeric mRNAs, composed of paraja ring finger 2 (PJA2) and FER. We detected no genomic rearrangements between PJA2 and FER and attributed these chimeric mRNAs to alterations at the transcriptome level: i.e., trans-splicing. Several chimeric patterns were detected concurrently in each patient, and the pattern sets varied among patients, although the pattern in which PJA2 exon 1 was fused to FER exon 3 (designated as Pe1-Fe3 mRNA) was detected constantly. Therefore, in a wide screening for PJA2-FER mRNAs in NSCLC, we focused on this chimeric pattern as a representative chimera. In analyses of 167 NSCLC samples, Pe1-Fe3 mRNA was identified in about 10% of the patients, and the presence of chimeric mRNA was significantly correlated with a high expression level of parental FER mRNA. Furthermore, we found that the detection of Pe1-Fe3 mRNA was correlated with poor postoperative survival periods in NSCLC, consistent with a previous finding in which FER overexpression was correlated with poor postoperative prognosis in NSCLC. This report is the first to suggest a correlation between chimeric mRNA and the expression level of parental mRNA. Furthermore, our findings may be clinically beneficial, suggesting that PJA2-FER mRNAs might serve as a novel prognostic biomarker in NSCLC.
© 2013 Japanese Cancer Association.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23931849      PMCID: PMC7654240          DOI: 10.1111/cas.12250

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  46 in total

Review 1.  Closing in on the biological functions of Fps/Fes and Fer.

Authors:  Peter Greer
Journal:  Nat Rev Mol Cell Biol       Date:  2002-04       Impact factor: 94.444

Review 2.  Alternative trans-splicing: a novel mode of pre-mRNA processing.

Authors:  Takayuki Horiuchi; Toshiro Aigaki
Journal:  Biol Cell       Date:  2006-02       Impact factor: 4.458

3.  Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy.

Authors:  Tomoshi Tsuchiya; Shinji Akamine; Masashi Muraoka; Ryotaro Kamohara; Koichi Tsuji; Shogo Urabe; Sumihisa Honda; Naoya Yamasaki
Journal:  Lung Cancer       Date:  2007-03-09       Impact factor: 5.705

Review 4.  Role of the non-receptor tyrosine kinase fes in cancer.

Authors:  F Condorelli; E Stec-Martyna; J Zaborowska; L Felli; I Gnemmi; M Ponassi; C Rosano
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

5.  Recurrent chimeric RNAs enriched in human prostate cancer identified by deep sequencing.

Authors:  Kalpana Kannan; Liguo Wang; Jianghua Wang; Michael M Ittmann; Wei Li; Laising Yen
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-12       Impact factor: 11.205

6.  Trans splicing of mRNA precursors.

Authors:  D Solnick
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

7.  p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin-alpha-catenin Interaction.

Authors:  Jose Piedra; Susana Miravet; Julio Castaño; Héctor G Pálmer; Nora Heisterkamp; Antonio García de Herreros; Mireia Duñach
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.

Authors:  David S Rickman; Dorothee Pflueger; Benjamin Moss; Vanessa E VanDoren; Chen X Chen; Alexandre de la Taille; Rainer Kuefer; Ashutosh K Tewari; Sunita R Setlur; Francesca Demichelis; Mark A Rubin
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

9.  Visceral pleural invasion classification in non-small cell lung cancer: a proposal on the basis of outcome assessment.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Tomoyuki Yokose; Genichiro Ishii; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2004-06       Impact factor: 5.209

Review 10.  Implications of chimaeric non-co-linear transcripts.

Authors:  Thomas R Gingeras
Journal:  Nature       Date:  2009-09-10       Impact factor: 49.962

View more
  8 in total

Review 1.  Trans-spliced long non-coding RNA: an emerging regulator of pluripotency.

Authors:  Chun-Ying Yu; Ching-Yu Chuang; Hung-Chih Kuo
Journal:  Cell Mol Life Sci       Date:  2018-06-30       Impact factor: 9.261

2.  m6A demethylase FTO suppresses pancreatic cancer tumorigenesis by demethylating PJA2 and inhibiting Wnt signaling.

Authors:  Juan Zeng; Heying Zhang; Yonggang Tan; Zhe Wang; Yunwei Li; Xianghong Yang
Journal:  Mol Ther Nucleic Acids       Date:  2021-06-24       Impact factor: 8.886

Review 3.  Chimeric RNAs Discovered by RNA Sequencing and Their Roles in Cancer and Rare Genetic Diseases.

Authors:  Yunan Sun; Hui Li
Journal:  Genes (Basel)       Date:  2022-04-22       Impact factor: 4.141

4.  Detection of novel paraja ring finger 2-fer tyrosine kinase mRNA chimeras is associated with poor postoperative prognosis in non-small cell lung cancer.

Authors:  Masanori Kawakami; Rie Ishikawa; Yosuke Amano; Mitsuhiro Sunohara; Kousuke Watanabe; Nobuya Ohishi; Yutaka Yatomi; Jun Nakajima; Masashi Fukayama; Takahide Nagase; Daiya Takai
Journal:  Cancer Sci       Date:  2013-09-05       Impact factor: 6.716

Review 5.  Evolutionary Insights into RNA trans-Splicing in Vertebrates.

Authors:  Quan Lei; Cong Li; Zhixiang Zuo; Chunhua Huang; Hanhua Cheng; Rongjia Zhou
Journal:  Genome Biol Evol       Date:  2016-03-10       Impact factor: 3.416

6.  The chimeric transcript RUNX1-GLRX5: a biomarker for good postoperative prognosis in Stage IA non-small-cell lung cancer.

Authors:  Rie Ishikawa; Yosuke Amano; Masanori Kawakami; Mitsuhiro Sunohara; Kousuke Watanabe; Hidenori Kage; Nobuya Ohishi; Yutaka Yatomi; Jun Nakajima; Masashi Fukayama; Takahide Nagase; Daiya Takai
Journal:  Jpn J Clin Oncol       Date:  2015-12-18       Impact factor: 3.019

7.  Identification of hub genes in bladder cancer based on weighted gene co-expression network analysis from TCGA database.

Authors:  Lei Wang; Xudong Liu; Miao Yue; Zhe Liu; Yu Zhang; Ying Ma; Jia Luo; Wuling Li; Jiangshan Bai; Hongmei Yao; Yuxuan Chen; Xiaofeng Li; Dayun Feng; Xinqiang Song
Journal:  Cancer Rep (Hoboken)       Date:  2021-09-20

8.  Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA.

Authors:  Matt R Paul; Nicholas P Levitt; David E Moore; Patricia M Watson; Robert C Wilson; Chadrick E Denlinger; Dennis K Watson; Paul E Anderson
Journal:  BMC Genomics       Date:  2016-03-31       Impact factor: 3.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.